FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 101 through 150 of 335

BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES - SIC # 2836

Ticker Exchange Company Financial Reports SIC #
CTCX Nasdaq Carmell Corporation 2836
CUE Nasdaq Cue Biopharma, Inc. 2836
CVAC Nasdaq CureVac N.V. 2836
CVKD Nasdaq Cadrenal Therapeutics, Inc. 2836
CYCC Nasdaq Cyclacel Pharmaceuticals, Inc. 2836
CYCN Nasdaq Cyclerion Therapeutics, Inc. 2836
CYTK Nasdaq Cytokinetics, Incorporated 2836
DAWN Nasdaq Day One Biopharmaceuticals, Inc. 2836
DCTH Nasdaq Delcath Systems, Inc. 2836
DMAC Nasdaq DiaMedica Therapeutics Inc. 2836
DNTH Nasdaq Dianthus Therapeutics, Inc. 2836
DRUG Nasdaq Bright Minds Biosciences Inc. 2836
DSGN Nasdaq Design Therapeutics, Inc. 2836
DWTX Nasdaq Dogwood Therapeutics, Inc. 2836
DYAI Nasdaq Dyadic International, Inc. 2836
DYN Nasdaq Dyne Therapeutics, Inc. 2836
EBS New York Emergent BioSolutions Inc. 2836
EDSA Nasdaq Edesa Biotech, Inc. 2836
ELDN Nasdaq Eledon Pharmaceuticals, Inc. 2836
ELEV Nasdaq Elevation Oncology, Inc. 2836
ELUT Nasdaq Elutia Inc. 2836
ELVN Nasdaq Enliven Therapeutics, Inc. 2836
ENLV Nasdaq Enlivex Therapeutics Ltd. 2836
ENTX Nasdaq Entera Bio Ltd. 2836
EPIX Nasdaq ESSA Pharma Inc. 2836
EQ Nasdaq Equillium, Inc. 2836
ERAS Nasdaq Erasca, Inc. 2836
ERNA Nasdaq Eterna Therapeutics Inc. 2836
ESPR Nasdaq Esperion Therapeutics, Inc. 2836
EXEL Nasdaq Exelixis, Inc. 2836
FATE Nasdaq Fate Therapeutics, Inc. 2836
FNCH Over the counter Finch Therapeutics Group, Inc. 2836
GALT Nasdaq Galectin Therapeutics Inc. 2836
GANX Nasdaq Gain Therapeutics, Inc. 2836
GELS Nasdaq Gelteq Limited 2836
GERN Nasdaq Geron Corporation 2836
GILD Nasdaq Gilead Sciences, Inc. 2836
GLPG Nasdaq Galapagos NV 2836
GLSI Nasdaq Greenwich LifeSciences, Inc. 2836
GLUE Nasdaq Monte Rosa Therapeutics, Inc. 2836
GLYC Nasdaq GlycoMimetics, Inc. 2836
GMED New York Globus Medical, Inc. 2836
GNLX Nasdaq Genelux Corporation 2836
GNPX Nasdaq Genprex, Inc. 2836
GOSS Nasdaq Gossamer Bio, Inc. 2836
GRAL Nasdaq GRAIL, Inc. 2836
HALO Nasdaq Halozyme Therapeutics, Inc. 2836
HCWB Nasdaq HCW Biologics Inc. 2836
HRGN Over the counter Harvard Apparatus Regenerative Technolog 2836
HUMA Nasdaq Humacyte, Inc. 2836
Results 100 through 150 of 335